Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials.

作者: Sin-Ho Jung

DOI: 10.1016/J.CCT.2015.02.007

关键词:

摘要: Abstract Background Phase II trials have been very widely conducted and published every year for cancer clinical research. In spite of the fast progress in design analysis methods, single-arm two-stage is still most popular phase trials. Because their small sample sizes, statistical methods based on large approximation are not appropriate Methods As a prospective research, method trial predetermined at stage it analyzed during end as planned by design. The should be matched with method. For single arm trials, Simon's has standards choosing an optimal design, but resulting data ignoring aspect sizes. Conclusions this article, we review that exactly get along exact We also discuss some to improve existing

参考文章(31)
Stefan Englert, Meinhard Kieser, Optimal adaptive two-stage designs for phase II cancer clinical trials. Biometrical Journal. ,vol. 55, pp. 955- 968 ,(2013) , 10.1002/BIMJ.201200220
Tatsuki Koyama, Heidi Chen, Proper inference from Simon's two-stage designs. Statistics in Medicine. ,vol. 27, pp. 3145- 3154 ,(2008) , 10.1002/SIM.3123
Myron N. Chang, Peter C. O'Brien, Confidence intervals following group sequential tests. Controlled Clinical Trials. ,vol. 7, pp. 18- 26 ,(1986) , 10.1016/0197-2456(86)90004-8
Adrian P. Mander, James M.S. Wason, Michael J. Sweeting, Simon G. Thompson, Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis. Pharmaceutical Statistics. ,vol. 11, pp. 91- 96 ,(2012) , 10.1002/PST.501
T. Timothy Chen, Tie-Hua Ng, Optimal flexible designs in phase II clinical trials. Statistics in Medicine. ,vol. 17, pp. 2301- 2312 ,(1998) , 10.1002/(SICI)1097-0258(19981030)17:20<2301::AID-SIM927>3.0.CO;2-X
Jack Bowden, James Wason, Identifying combined design and analysis procedures in two-stage trials with a binary end point Statistics in Medicine. ,vol. 31, pp. 3874- 3884 ,(2012) , 10.1002/SIM.5468
Henry B. Koon, Susan E. Krown, Jeannette Y. Lee, Kord Honda, Suthee Rapisuwon, Zhenghe Wang, David Aboulafia, Erin G. Reid, Michelle A. Rudek, Bruce J. Dezube, Ariela Noy, Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042 Journal of Clinical Oncology. ,vol. 32, pp. 402- 408 ,(2014) , 10.1200/JCO.2012.48.6365
Meinhard Kieser, Stefan Englert, Performance of Adaptive Designs for Single-Armed Phase II Oncology Trials Journal of Biopharmaceutical Statistics. ,vol. 25, pp. 602- 615 ,(2015) , 10.1080/10543406.2014.920863
MYRON N. CHANG, A. LAWRENCE GOULD, STEVEN M. SNAPINN, P-values for group sequential testing Biometrika. ,vol. 82, pp. 650- 654 ,(1995) , 10.1093/BIOMET/82.3.650